Le Lézard
Classified in: Health
Subjects: PDT, PLW

Xoran Announces New Patent for Modular Computed Tomography System Assembly


ANN ARBOR, Mich., June 8, 2022 /PRNewswire/ -- Xoran Technologies has recently received a patent for a modular computed tomography (CT) system assembly.

"... this advancement means that ultra-compact CT can fit into existing ambulances for early stroke detection ... " 

"This revolutionary cone beam CT configuration paired with our twenty-and-counting current patents unlocks new capabilities. The technology is just the beginning of a new generation of Xoran's point-of-care (POC) imaging devices," explains Misha Rakic, Xoran CEO. "In the future, this advancement means that ultra-compact CT can fit into existing ambulances for early stroke detection without the need for a dedicated mobile stroke unit. It can be used by first responders in front-line and natural disaster scenarios as well as by military on the battlefield. The possibilities for highly deployable head CT are virtually limitless."

Over 795,000 individuals suffer from strokes each year in the U.S. alone. When an individual is suffering from acute stroke, time is of the essence; however, it is critically important to assess the type of stroke as well as the amount and location of potentially recoverable brain tissue to determine the appropriate treatment routing and priority to achieve the best outcome for that individual.

Xoran Technologies has patented and prototyped a novel, highly compact cranial CT device, which could in the future enable cerebral perfusion studies to be performed in a wider range of clinical settings, to service more patients?rapidly and at the POC after the onset of stroke symptoms.

About Xoran Technologies

Since 2001, Xoran has been the pioneer and medical market leader in low-dose radiation, cone beam CT systems specifically designed for the patient's point-of-care. Providers around the world rely on our industry-leading MiniCATtm, xCATtm, and veterinary CT systems: VetCAT and vTRON, to diagnose and treat patients.

Xoran is based in Ann Arbor, Michigan.

For more information visit www.xorantech.com

© 2022 Xoran Technologies, LLC

SOURCE Xoran Technologies, LLC


These press releases may also interest you

at 06:50
Pfizer Inc. today announced that Andrew Baum, M.D., will join the company as Chief Strategy and Innovation Officer, Executive Vice President. Dr. Baum will be a member of Pfizer's Executive Leadership Team reporting to Chairman and Chief Executive...

at 06:30
Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following investor and scientific...

at 06:25
Genenta Science , a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power of hematopoietic stem cells to provide durable and safe treatments for solid tumors, announces that it held its Ordinary and...

at 06:19
Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies has launched Eroxon® in Sweden. Eroxon® is clinically proven and considered a breakthrough in treatment of erectile...

at 06:05
Soleo Health, an innovative leader and national provider of complex specialty pharmacy services for treating rare- and ultra-rare diseases, announced today it has been named a limited distribution specialty pharmacy partner to dispense RYPLAZIM®...

at 06:05
GlycoMimetics, Inc. , a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced topline results from its Phase 3 global pivotal study of uproleselan in...



News published on and distributed by: